Literature DB >> 19941899

Receptors and ligands implicated in human T cell costimulatory processes.

Judith Leitner1, Katharina Grabmeier-Pfistershammer, Peter Steinberger.   

Abstract

It is well established that full activation of T cells that recognize antigens requires additional signals. These second signals are generated by the interaction of costimulatory ligands expressed on antigen presenting cells with their receptors on T cells. In addition, T cell activation processes are negatively regulated by inhibitory costimulatory pathways. Interaction of members of the B7 and the TNF superfamilies with members of the CD28 and TNF-R-superfamilies plays major roles in costimulatory processes. However, a large number of molecules that do not belong to these families have been reported to be involved in the generation of T cell costimulatory signals. In addition to well-defined costimulatory pathways, where both receptors and ligands are known, there are many T cell surface molecules that have been described to generate a second signal under certain experimental conditions, f.i. when ligated with antibodies. Furthermore there are several ligands that have been shown to positively or negatively modulate T cell activation by interacting with as of yet unknown T cell receptors. Here we give a comprehensive overview of molecules that have been implicated in human T cell activation processes and propose criteria that define genuine T cell costimulatory pathways. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941899     DOI: 10.1016/j.imlet.2009.11.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  28 in total

1.  Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Authors:  Qing Li; Xuedong Ding; Jeremy J Thomas; Clifford V Harding; Nicole D Pecora; Assem G Ziady; Samuel Shank; W Henry Boom; Christina L Lancioni; Roxana E Rojas
Journal:  J Leukoc Biol       Date:  2011-12-07       Impact factor: 4.962

2.  Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Authors:  Christina L Lancioni; Qing Li; Jeremy J Thomas; XueDong Ding; Bonnie Thiel; Michael G Drage; Nicole D Pecora; Assem G Ziady; Samuel Shank; Clifford V Harding; W Henry Boom; Roxana E Rojas
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  [Mag. Dr. Judith Leitner: Medical University of Vienna Researcher of the Month, October 2013].

Authors:  Judith Leitner
Journal:  Wien Klin Wochenschr       Date:  2013-10       Impact factor: 1.704

Review 4.  Impact of microbes on autoimmune diseases.

Authors:  Claudia Danzer; Jochen Mattner
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-16       Impact factor: 4.291

5.  B7-H6 expression in non-small cell lung cancers.

Authors:  Xiuqin Zhang; Guangbo Zhang; Yan Qin; Ruizhen Bai; Jianan Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

6.  ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.

Authors:  Iris Hecht; Amir Toporik; Joseph R Podojil; Ilan Vaknin; Gady Cojocaru; Anat Oren; Elizabeta Aizman; Spencer C Liang; Ling Leung; Yosef Dicken; Amit Novik; Nadav Marbach-Bar; Aziza Elmesmari; Clare Tange; Ashley Gilmour; Donna McIntyre; Mariola Kurowska-Stolarska; Kay McNamee; Judith Leitner; Shirley Greenwald; Liat Dassa; Zurit Levine; Peter Steinberger; Richard O Williams; Stephen D Miller; Iain B McInnes; Eyal Neria; Galit Rotman
Journal:  J Immunol       Date:  2018-02-05       Impact factor: 5.422

Review 7.  Lymph node stroma broaden the peripheral tolerance paradigm.

Authors:  Anne L Fletcher; Deepali Malhotra; Shannon J Turley
Journal:  Trends Immunol       Date:  2010-12-10       Impact factor: 16.687

8.  TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.

Authors:  Chang Hoon Lee; Patricia Masso-Welch; George Hajishengallis; Terry D Connell
Journal:  J Leukoc Biol       Date:  2011-07-26       Impact factor: 4.962

9.  A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood.

Authors:  Karl Welzenbach; Riccardo V Mancuso; Stephan Krähenbühl; Gabriele Weitz-Schmidt
Journal:  Br J Pharmacol       Date:  2015-10-19       Impact factor: 8.739

10.  Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency.

Authors:  Vanessa A Evans; Renée M van der Sluis; Ajantha Solomon; Ashanti Dantanarayana; Catriona McNeil; Roger Garsia; Sarah Palmer; Rémi Fromentin; Nicolas Chomont; Rafick-Pierre Sékaly; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.